supports the hypothesis that GPIb is involved in the ristocetininduced binding of vWf, while the GPIIb-GPIIIa complex, but not GPIb, is involved in the expression of thrombin-or ADP + epinephrine-induced platelet receptors for vWf.
To obtain additional insight into the structure and function of GPIb and its relationship to other membrane and nonmembrane components, we purified the glycoprotein by immunoaffinity chromatography. Since Solum et al. (23) had reported that GPIb may be associated in complexes that are disrupted by the endogenous calcium-activated neutral protease (CANP), we analyzed lysates prepared in the presence or absence of inhibitors of CANP. As noted in a preliminary report (9) , this experimental approach confirmed the existence of soluble complexes of GPIb and a 240,000-260,000-mol-wt platelet protein. We now report the identification of this protein as actin-binding protein (ABP).
MATERIALS AND METHODS
Monoclonal IgG was isolated from ascites fluids and labeled with ~25I as previously described (1 1, 17) . Crossed immunoelectrophoresis (CIE) was per-formed as previously described, incorporating labeled monoclonal IgG into the intermediate gel (8, 11) , and precipitin arcs containing bound monoclonal antibody were revealed by autoradiograpby. Immunoaffinity chromatography using AP 1 coupled to Sepharose CL4B (Pharmacia Fine Chemicals, Piscataway, N J) and assays of the direct binding of [~:~I]AP1 to platelets were performed as described (17) . SDS PAGE was performed in 3-mm thick, 7 % acrylamide slab gels as described by Nurden et al. (14) . Apparent molecular weights were calculated by direct comparison to the mobilities of the following known protein standards (Bio-Rad Laboratories, Richmond, CA): myosin (200,000); betagalactosidase (117,000); phosphorylase b (94,000); bovine serum albumin (69,000); and ovalbumin (43,000).
Immunoblot Method: After SDS PAGE, gels were incubated in 0.025 M Tris-HC1, 0.192 M glyeine, 20% (vol/vol) methanol (pH 8.2) for 30 rain at ambient temperatures and sandwiched against a nitrocellulose membrane (Bio-Rad Laboratories) in a Transblot apparatus (Bio-Rad). Proteins were transferred by electrophoresis at 60 V for 3 h and 30 min at 4"C. Nonreacted nitrocellulose was then blocked by incubation for 1 h in 0.01 M Tris-HC1, 0.145 M NaCI (pH 7.0) containing 1% gelatin, followed by two 10-rain washes in the same buffer containing 0.5% gelatin, 0.5% Triton X-100 and 0.01% NAN,. The membrane was then incubated for 18 h with agitation in 50 ml of the latter mixture containing 0.25 ml of goat antiserum raised against rabbit macrophage ABP. This antiserum, a generous gift from John H. Hartwig, Ph.D. (Hematology-Oncology Unit, Massachusetts General Hospital, Boston) cross-reacts with ABP from human platelets 2. The membrane was then washed five times in the same buffer mixture without antiserum, incubated for 6 h in 50 ml of the same buffer mixture containing affinity-purified, [~2~l]-rabbit anti-goat IgG (l0 s cpm/ml [Zymed Labs, Inc., So. San Francisco, CA]), and finally washed five times in the same buffer mixture containing 0.2% SDS. The membrane was immediately blotted without drying and packaged within a plastic bag. For autoradiography, membranes within plastic bags were sandwiched between Kodak XRP-I x-ray film and a Dupont Cronex Hi Plus Intensifying screen for I to 24 h at ambient temperature in a light-proof Kodak x-ray film cassette.
Additional murine monoclonal antibodies were used in these studies: antifibronectin (ATCC CRL 1605) was obtained commercially; anti-vWf (AVW2), reactive with all multimers, was produced in the laboratory of Dr. Robert Montgomery (21) .
Piatelet cytoskeletons, as a source of semi-purified ABE were prepared as described by Rosenburg et at. (19) , except that 0.01 M HEPES was used in place of 0.01 M imidazole-chloride in the "Triton solubdization buffer." This modification was without apparent effect upon the composition of the cytoskeleton complex subsequently isolated.
RESULTS

Steady-state Binding of AP1 to Human Platelets
On the basis of data derived from eight different healthy donors, we found that the number of API molecules bound per platelet at saturation was 34,200 _+ 5,400 (mean _-!-SD), with an average dissociation constant (Kd) of 2. l _+ 0.4 nM. No difference in binding was noted at room temperature in the presence or absence of divalent cations. Comparative studies with washed platelets derived from whole blood anticoagulated with citrate, EDTA, acid-citrate-dextrose, or heparin gave equivalent results.
CIE
[125I]AP1 was incorporated into the intermediate gel before the start of the second dimension electrophoresis, and the precipitin arcs containing antigens reactive with AP1 were revealed by autoradiography of the dried gels ( Fig. 1) . When platelets were lysed in the absence of leupeptin or EDTA, AP1 bound solely to two cross-reactive precipitin arcs known from previous studies (6) to contain GPIb and glycocalicin, respectively ( Fig. 1 B) . In lysates from identical platelets prepared in the presence of 0.4 mM leupeptin ( Fig. 1 A) , at least two additional cathodic precipitin arcs were labeled by ['25I]-A P I , o n e o f w h i c h w a s a sharp " s p i k e " situated directly o v e r 2 j. Hartwig, personal communication.
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RAPID COMMUNICATIONS FIGURE 1 ClE. Identical washed platelet samples were lysed in the presence (A) or absence (B) of 0.4 mM leupeptin. Triton X-100 soluble protein (100 #g) was electrophoresed against a mixture of polyspecific rabbit anti-human platelet antibody and ['2Sl]API. Gels were stained with CBR, dried, and subjected to autoradiography. The resultant autoradiographs were depicted below the corresponding CBR-stained gel. The position of the precipitin arcs given by GPIb and glycocalicin (G) are indicated. Arrowheads in gel A indicate the additional cathodic precipitin arcs to which [12Sl]AP1 also bound.
the sample well (open arrowhead in Fig. 1A ). Essentially the same results were obtained from lysates prepared in the presence of 5 mM EDTA, although the spike precipitin arc was not as pronounced as that seen in lysates prepared with leupeptin. Radiolabeled, monoclonal antifibronectin and anti-vWf (AVW2) bound to respective precipitin arcs known to contain these antigens, but neither bound to the cathodic precipitin arcs reactive with radiolabeled AP1 (data not shown).
Immunoaffinity Chromatography
Purified API IgO was covalently coupled to cyanogen bromide-activated Sepharose CL4B. Triton X-100 lysates derived from the same preparation of washed, 125I-labeled platelets, in the absence or presence of 0.4 mM leupeptin, were chromatographed on identical AP1-Sepharose columns equilibrated in buffer containing leupeptin. Bound protein was eluted b y a m u l t i s t e p e l u t i o n p r o t o c o l (17); the final elution buffer contained 0.05 M diethylamine (pH 11.5). Each eluate was then analyzed by SDS PAGE. Protein bands were visualized by staining with Commassie Blue-R (CBR) or periodic acid-Schiff reagent (PAS).
When lysates prepared in the presence of leupeptin were analyzed, a PAS-positive, radiolabeled protein with an electrophoretic mobility following reduction with 2-mercaptoethanol characteristic of the larger subunit, or alpha chain, (145,000-mol-wt), of GPIb was eluted only upon addition of diethylamine (Fig. 2, solid arrowhead in lanes A-C) . A PASpositive band of identical mobility and present in the original lysate (Fig. 2, lane 1) was seen to be depleted from the nonadherent fraction (Fig. 2, lane 2) . In addition to GPIb alpha, the diethylamine-eluate contained a high molecular weight protein (240,000-260,000) that was stained by CBR (Fig. 2, open arrowhead in lane A) , but PAS-negative and nonradiolabeled (Fig. 2, lanes B and C) . Eluates derived by addition of 1 M NaC1 often contained detectable amounts of the 240,000-260,000-mol-wt protein, but never contained a protein band equivalent to GPIb alpha. Identical proteins were contained in diethylamine-eluates derived from lysates prepared in the presence of 5 mM EDTA.
When lysates prepared in the absence ofleupeptin or EDTA were analyzed, diethylamine-eluates were found to contain two closely migrating protein bands (with molecular weights of 140,000 and 135,000) that were both PAS-positive and radiolabeled (Fig. 2, arrows in lane D) . Based upon these apparent molecular weights, the former protein is likely GPIb; the latter, glycocalicin. No trace of the 240,000-260,000-molwt protein was detected either in diethylamine-eluates or 1 M NaCl-eluates derived from lysates prepared in the absence of leupeptin or EDTA.
Immunoblot
As shown in Fig. 3 , the platelet lysate used to generate purified GPIb (lane A) was directly compared to a cytoskeleton complex preparation enriched in ABP (lane B), and the fraction containing the GPIb-high molecular weight protein complex eluted from an AP 1-Sepharose affinity column (lane C). By this method, the 240-260,000-mol-wt protein that is co-purified with GPIb (cf. Fig. 2, lane A) was shown to crossreact with antibody specific for ABP.
Specificity of AP1
As shown previously, AP 1 reacts with OPIb and glycocalicin (9, 11, 20) . In the present study, it was necessary to show that AP1 does not also react with ABP leading to artifactual isolation of ABP along with GPIb. The monoclonal antibody, AP 1, is nonreactive in the SDS PAGE immunoblot technique. Thus, it became necessary to isolate ABP from GPIb. As it has been difficult to prepare an ABP preparation that does not contain some contamination of GPIb, we used platelets from a patient with the BSS which lack GPIb (13). A cytoskeletal preparation from BSS platelets contains ABP as demonstrated by immunoblot technique with goat anti-ABP serum. Reaction of AP1 with the cytoskeletal preparation from BSS platelets could not be detected using an ELISA technique. The cytoskeletal preparation was adsorbed onto Immulon I plates (Dynatech Laboratories, Inc., Alexandria, "CA) and reaction with API assayed using the biotin/avidin system for mouse IgG detection (Vector Laboratories, Inc., Burlingame, CA). 
D I S C U S S I O N
Based upon partial immunologic identity and similarities in tryptic peptide maps, there is now little doubt that GPIb and glycocalicin are structurally related (1, 15, 22) , and that glycocalicin is derived from GPIb by the action of an endogenous CANP (10, 22, 23, 25) .
Using CIE, Solum et al. (23) demonstrated that cleavage of GPIb by CANP can occur within intact platelets stimulated with local anesthetics, such as dibucaine, and that the mobility of GPIb within the first dimension of CIE gels is impeded in lysates prepared under conditions that would inhibit the endogenous CANP. Activation of the endogenous CANP in intact platelets with the ionophore A23187 in the presence of calcium has also been shown to result in the proteolysis of GPIb with release of glycocalicin (10) . An additional substrate of CANP, ABP, has also been shown to be cleaved concomitant with platelet activation by thrombin or A23187 (7, 16, 24) . Thus, it has been postulated that proteolysis of selected substrates, perhaps GPIb and/or ABP, by CANP may be a requisite step in platelet activation.
The results of our studies confirm and extend the initial observation of Solum et al. (23) , demonstrating the existence of complexes of GPIb and a 240,000-260,000-mol-wt protein.
The identification of this protein as ABP is based upon the following facts: (a) it is CBR-positive but PAS-negative and thus not likely a glycoprotein (Fig. 2) ; (b) it is not surfacelabeled with 125I by the lactoperoxidase method (Fig. 2) or with 3H by periodate oxidation and reduction with sodium borotritide3; (c) it has an electrophoretic mobility in SDS PAGE identical to that of ABP (Fig. 3) ; and, most important, (d) it cross-reacts with antibodies specific for ABP (Fig. 3) . Our data do not permit us to conclude that there is a direct linkage between GPIb and ABP, and the possibility that this association is mediated by additional platelet proteins remains to be investigated. In a preliminary communication, Fox et al. (6) reported that GPIb is linked to a 250,000-mol-wt polypeptide in platelet cytoskeletons, but the protein in question was not identified. In view of our findings, it is likely that the association described by Fox et al. (6) is identical to the GPIb-ABP interaction reported herein. The finding of GPIb-ABP complexes in platelet lysates as T. J. Kunicki, unpublished observation. described in this report or of a linkage between tritiated GPIb and the Triton-insoluble cytoskeleton as described by Fox et at. (6) would suggest that a transmembrane linkage exists between GPIb and ABP in the intact platelet. The potential physiologic relevance of such an interaction is compelling, and one can imagine that this transmembrane interaction could limit the mobility of both components in nonactivated platelets until the linkage is destroyed by activation of CANP. However, the possibility that this association only occurs subsequent to platelet disruption must be considered, and a more rigorous confirmation of this hypothesis would entail analyses of the association(s) of GPIb within inta~ platelets.
Aside from its association with a 17,000-22,000-mol-wt minor glycoprotein, known as GPIX or GPI7 (2, 4, 14) , the use of immunoelectron microscopy (18) or chemical cross-linking reagents (5) has not revealed any significant interaction between GPIb and other platelet proteins. However, the failure to observe such interactions with the latter method (5) may be related to the relative difficulty in detecting GPIb with protein-specific stains or by surface-radioiodination of platelets.
Given that a transmembrane linkage between GPIb and the cytoskeleton does exist in intact platelets, one might expect that agents that would perturb this interaction could also influence GPIb receptor function. In this regard, Coller (3) has recently reported that tertiary amine local anesthetics initially cause an increase in the rate of vWf-dependent platelet aggregation, whereas prolonged exposure to these agents produces a significant inhibition of vWf-dependent platelet agglutination that is temporally correlated with proteolysis of GPIb. Since such local anesthetics are also known to rapidly induce reversible platelet-sphering and retraction of pseudopodia in the absence of proteolysis (12) , it is conceivable that the enhanced vWf-dependent aggregation observed by Coller (3) is due to an increased mobility of vWf receptors (GPIb) caused by disruption of the GPIb-cytoskeleton interaction. Prolonged exposure to these agents sufficient to cause proteolysis of GPIb and/or ABP results in irreversible inhibition of vWf-dependent agglutination (3) and irreversible plateletsphering (12) . Studies are now in progess to analyze in greater detail the effect of GPIb-ABP complex integrity upon platelet functions attributed to GPIb.
